Entero Therapeutics, Inc. Quarterly Return On Assets in % from Q2 2017 to Q1 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Entero Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q2 2017 to Q1 2024.
  • Entero Therapeutics, Inc. Return On Assets for the quarter ending March 31, 2024 was -22.8 %, a 87.8% increase year-over-year.
  • Entero Therapeutics, Inc. annual Return On Assets for 2023 was -279 %, a 8.75% decline from 2022.
  • Entero Therapeutics, Inc. annual Return On Assets for 2022 was -256 %, a 38.7% increase from 2021.
  • Entero Therapeutics, Inc. annual Return On Assets for 2021 was -418 %, a 43.1% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2024 -22.8 +163 +87.8% Jan 1, 2024 Mar 31, 2024
Q4 2023 -279 -22.4 -8.75% Oct 1, 2023 Dec 31, 2023
Q3 2023 -295 +3.53 +1.18% Jul 1, 2023 Sep 30, 2023
Q2 2023 -158 +455 +74.3% Apr 1, 2023 Jun 30, 2023
Q1 2023 -186 +331 +64.1% Jan 1, 2023 Mar 31, 2023
Q4 2022 -256 +162 +38.7% Oct 1, 2022 Dec 31, 2022
Q3 2022 -299 +155 +34.1% Jul 1, 2022 Sep 30, 2022
Q2 2022 -613 -354 -137% Apr 1, 2022 Jun 30, 2022
Q1 2022 -517 -259 -101% Jan 1, 2022 Mar 31, 2022
Q4 2021 -418 -126 -43.1% Oct 1, 2021 Dec 31, 2021
Q3 2021 -454 -291 -179% Jul 1, 2021 Sep 30, 2021
Q2 2021 -258 -73.6 -39.8% Apr 1, 2021 Jun 30, 2021
Q1 2021 -258 -83 -47.5% Jan 1, 2021 Mar 31, 2021
Q4 2020 -292 -128 -77.8% Oct 1, 2020 Dec 31, 2020
Q3 2020 -163 +39.2 +19.4% Jul 1, 2020 Sep 30, 2020
Q2 2020 -185 +3.4 +1.81% Apr 1, 2020 Jun 30, 2020
Q1 2020 -175 -16.1 -10.2% Jan 1, 2020 Mar 31, 2020
Q4 2019 -164 -0.62 -0.38% Oct 1, 2019 Dec 31, 2019
Q3 2019 -202 -47.5 -30.7% Jul 1, 2019 Sep 30, 2019
Q2 2019 -188 -16.9 -9.85% Apr 1, 2019 Jun 30, 2019
Q1 2019 -159 +22.6 +12.5% Jan 1, 2019 Mar 31, 2019
Q4 2018 -164 +3.6 +2.15% Oct 1, 2018 Dec 31, 2018
Q3 2018 -155 +50.6 +24.7% Jul 1, 2018 Sep 30, 2018
Q2 2018 -171 +44.4 +20.6% Apr 1, 2018 Jun 30, 2018
Q1 2018 -181 Jan 1, 2018 Mar 31, 2018
Q4 2017 -167 Oct 1, 2017 Dec 31, 2017
Q3 2017 -205 Jul 1, 2017 Sep 30, 2017
Q2 2017 -216 Apr 1, 2017 Jun 30, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.